JMIR DiabetesPub Date : 2026-11-09DOI: 10.2196/105115
Carly Brown, Sachin Karki, Vishnu Garla
{"title":"Clinical Outcomes of Multidisciplinary Remote Patient Monitoring for Patients With Poorly Controlled Type 2 Diabetes: Retrospective Cohort Study.","authors":"Carly Brown, Sachin Karki, Vishnu Garla","doi":"10.2196/105115","DOIUrl":"10.2196/105115","url":null,"abstract":"<p><strong>Background: </strong>Multidisciplinary remote patient monitoring (RPM) programs may support diabetes management by enabling ongoing glucose monitoring and timely treatment adjustments between clinical encounters. Evidence describing real-world implementation of RPM programs for diabetes in high-risk populations remains limited.</p><p><strong>Objective: </strong>This study evaluated clinical outcomes of a multidisciplinary RPM program for patients with uncontrolled type 2 diabetes mellitus (T2DM).</p><p><strong>Methods: </strong>Adults with T2DM, hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) >7%, and insulin therapy who enrolled in an RPM program at the University of Mississippi Medical Center between July 2020 and December 2022 were included. Patients received a Bluetooth-enabled glucometer and structured follow-up from nurses and pharmacists operating under a collaborative practice agreement. A propensity score-matched control group receiving usual outpatient care was identified. The primary outcome was the change in HbA<sub>1c</sub> from baseline to follow-up. Secondary outcomes included acute care use and RPM engagement, including program completion.</p><p><strong>Results: </strong>Among 109 RPM participants, mean HbA<sub>1c</sub> decreased from 10.79% (SD 2.35%) to 8.85% (-1.94 percentage points). In the matched cohort of 95 RPM and 95 control patients, HbA<sub>1c</sub> decreased by 1.97 versus 1.71 percentage points, respectively (between-group difference: -0.27, 95% CI -1.01 to 0.47; <i>P</i>=.48). Among matched RPM participants, program completers (n=19) had greater HbA<sub>1c</sub> reductions than noncompleters (n=76; -3.41 vs -1.61 percentage points; <i>P</i>=.01). Acute care use occurred in 13.7% of RPM participants versus 24.2% of matched controls; rates were 23.4 versus 24.2 per 100 person-years, respectively.</p><p><strong>Conclusions: </strong>Substantial improvements in glycemic control were observed among patients with uncontrolled T2DM enrolled in a multidisciplinary RPM program. Greater HbA<sub>1c</sub> reductions were observed among program completers, although this exploratory finding may reflect response-related selection because program completion required achievement of the program's glycemic target. Further study is needed to determine the comparative effectiveness of RPM and strategies to sustain patient engagement.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e105115"},"PeriodicalIF":2.9,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149381839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-11-09DOI: 10.2196/98957
Sofia Pfeffer, Elvis Safary, Aida Abraimova, Stéphane Besançon, Asel Dunganova, Cathy Haldane, Maria Lazo-Porras, Molly Lepeska, Moise Nguemeni, Silvana Perez-Leon, Kaushik Ramaiya, Priyanka Singh, Beatrice Vetter, David Beran
{"title":"Caregiver Perceptions of Blood Glucose Monitoring in Children and Adolescents Living With Type 1 Diabetes in Kyrgyzstan, Mali, Tanzania, and Peru: Qualitative Study.","authors":"Sofia Pfeffer, Elvis Safary, Aida Abraimova, Stéphane Besançon, Asel Dunganova, Cathy Haldane, Maria Lazo-Porras, Molly Lepeska, Moise Nguemeni, Silvana Perez-Leon, Kaushik Ramaiya, Priyanka Singh, Beatrice Vetter, David Beran","doi":"10.2196/98957","DOIUrl":"10.2196/98957","url":null,"abstract":"<p><strong>Background: </strong>Caregivers play an important role in caring for children and adolescents with type 1 diabetes. Controlling blood glucose levels is an essential part of diabetes management. Previous studies in low- and middle-income countries have found that tools for measuring blood glucose are unavailable and unaffordable. However, very little is known about the perceptions of caregivers in low- and middle-income countries with regard to the important element of self-monitoring of blood glucose in type 1 diabetes and emerging technologies and their suitability for these contexts.</p><p><strong>Objective: </strong>The aim of this study was to explore caregivers' perceptions of how self-monitoring of blood glucose impacts everyday life. For the purpose of this study, the term \"caregiver\" refers to either a parent or an adult responsible for assisting with the management of type 1 diabetes in a child/adolescent.</p><p><strong>Methods: </strong>This qualitative descriptive study involved 24 interviews with caregivers identified through a mix of purposive and snowball sampling. Interviews were carried out based on common themes from an interview guide. This study was part of a larger study conducted in Kyrgyzstan, Mali, Peru, and Tanzania. Interviews were analyzed using thematic analysis.</p><p><strong>Results: </strong>A total of 24 interviews were conducted, with over 80% of caregivers being female. The tools used raised issues related to blood glucose meters, such as finger pricks, follow-up, and affordability. Whereas for continuous glucose monitors, issues of acceptability, accessibility, and affordability of these devices were mentioned by the interviewees. Interviewees also highlighted different disruptions to daily life due to type 1 diabetes, such as nutrition, school, and the need to access medical care. Across settings, caregivers described substantial psychological burden linked to repeated finger pricks, financial strain, and challenges managing diabetes during school and nighttime periods.</p><p><strong>Conclusions: </strong>Caregivers' perspectives on blood glucose monitoring highlighted the psychological and financial burden that weighs on them. Technological solutions, such as continuous glucose monitors, make it possible to alleviate certain obstacles related to the use of blood glucose meters and strips, but given their high cost, this can increase the financial burden.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e98957"},"PeriodicalIF":2.9,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149381838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-10-27DOI: 10.2196/88446
Barbara Annancy, Pieter Van Bostraeten, Charlien Janssen, Steve Van den Bulck, Roman Vangoitsenhoven, Geert Goderis
{"title":"Perspectives on Self-Management and Digital Tools for Individuals With Type 2 Diabetes in Flanders: Qualitative Focus Group Study.","authors":"Barbara Annancy, Pieter Van Bostraeten, Charlien Janssen, Steve Van den Bulck, Roman Vangoitsenhoven, Geert Goderis","doi":"10.2196/88446","DOIUrl":"https://doi.org/10.2196/88446","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes (T2DM) is one of the leading chronic diseases worldwide, requiring effective long-term self-management (SM) to improve health outcomes and reduce complications. Although structured diabetes pathways exist in Belgium, national reports indicate that adherence to the recommended diabetes follow-up and routine monitoring remains suboptimal. Digital health technologies have shown promise in supporting SM; however, little is known about how stakeholders within the Flemish health care system perceive opportunities to improve SM and implement digital health interventions.</p><p><strong>Objective: </strong>This study aimed to explore stakeholders' perspectives on improving diabetes SM and the potential role of digital tools in supporting people with T2DM in the Flemish health care system.</p><p><strong>Methods: </strong>A qualitative study was conducted using 2 online semistructured focus group discussions with 19 stakeholders, including health care professionals (HCPs) from primary, secondary, and tertiary care settings; researchers; digital health experts; and an individual living with T2DM. Participants were recruited using maximum variation purposive sampling followed by snowball sampling. The discussion guide was informed by the Consolidated Framework for Implementation Research and current evidence on diabetes SM and digital health. Discussions were audio-recorded, transcribed verbatim, translated from Dutch into English, analyzed using Braun and Clarke's 6-phase reflexive thematic analysis, and supported by NVivo (QSR International).</p><p><strong>Results: </strong>Five key themes were identified: (1) Empowerment through education, (2) Tailoring education to individual needs, (3) Multidisciplinary and cross-sectoral collaboration, (4) Opportunities for digital technology in self-management, and (5) Regional and national systemic limitations. Participants consistently emphasized that effective diabetes SM may extend beyond patients' individual behaviors and depends on tailored education, coordinated multidisciplinary care across the health care sectors, supportive organizational structures, and supportive health policies. Digital health technologies were perceived as valuable tools to facilitate patient education, communication, information sharing, and continuity of care. However, participants also highlighted that successful implementation depends on addressing broader organizational and system-level barriers, including fragmented digital infrastructures, limited interoperability, and regulatory constraints within the Belgian health care system.</p><p><strong>Conclusions: </strong>Stakeholders viewed improving diabetes SM as a shared responsibility between patients, HCPs, and the health care system. While digital health technologies may strengthen SM support, their value depends on how well they complement existing care processes and address contextual implementation challenges. These findings provid","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e88446"},"PeriodicalIF":2.9,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13712406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149289942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-10-07DOI: 10.2196/91729
Beyza Cinar, Louisa van den Boom, Maria Maleshkova
{"title":"Data, Process, and Data-Driven Representations of Digital Twins in Diabetes: Scoping Review.","authors":"Beyza Cinar, Louisa van den Boom, Maria Maleshkova","doi":"10.2196/91729","DOIUrl":"10.2196/91729","url":null,"abstract":"<p><strong>Background: </strong>Diabetes is a chronic metabolic condition characterized by impaired blood glucose regulation. It is often linked to serious health complications and comorbidities that significantly affect quality of life, requiring effective management, continuous monitoring, and advanced data analytics. Notably, tailored diabetes management can be enhanced by digital twins (DTs), which serve as adaptive digital representations of patients, using clinical, physiological, and lifestyle data.</p><p><strong>Objective: </strong>This review explores diabetes-related DTs by examining their patient representation levels. We aim to synthesize the current state of the art and outline the foundations of a holistic, multilevel, multifunctional personalized DT for diabetes management.</p><p><strong>Methods: </strong>We investigate requirements for a personalized holistic DT and classify existing approaches into three representation levels: (1) data representation, involving structured, context-aware, and AI-ready data architectures that support data analysis, enable semantic interoperability, relationship extraction, and real-time bidirectional data exchange between patient and virtual replica. (2) Process representation, primarily based on mechanistic models simulating glucose-insulin-meal and exercise-glucose dynamics. (3) Data-driven representation, focusing on individualization through predictive modeling of disease onset, adverse events, and the generation of explainable, personalized recommendations. The literature is synthesized to provide a holistic, multilevel perspective on DTs, and to identify research gaps.</p><p><strong>Results: </strong>DTs accompany patients throughout their lifecycle and span a wide range of use cases, from long-term disease prediction to timely prediction of severe events. However, personalized DTs remain at an early stage of development. Most existing systems primarily function as simulation tools and lack comprehensive integration of data, processes, and data-driven representations. Key gaps include limited use of standardized semantic data models and ontologies, insufficient real-time bidirectional architectures, and fragmented integration of mechanistic and machine learning models, which are often treated as independent rather than complementary components.</p><p><strong>Conclusions: </strong>Although DTs hold substantial potential to advance personalized diabetes care, current implementations remain fragmented and incomplete. Future research should prioritize the development of holistic, multilevel DTs that integrate interoperable data infrastructures, mechanistic simulations, and data-driven models into cohesive, personalized systems capable of supporting lifelong disease management.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e91729"},"PeriodicalIF":2.9,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149129054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-10-06DOI: 10.2196/93074
Youssef Chninou, Johannes Edholm, Jenny Engvall, Sofia Wahlqvist, Claudia Schien, Anna Winkvist, Julia Otten
{"title":"An eHealth-Delivered Total Diet Replacement Intervention for Type 2 Diabetes Remission: Single-Arm Pilot Study.","authors":"Youssef Chninou, Johannes Edholm, Jenny Engvall, Sofia Wahlqvist, Claudia Schien, Anna Winkvist, Julia Otten","doi":"10.2196/93074","DOIUrl":"10.2196/93074","url":null,"abstract":"<p><strong>Background: </strong>The Diabetes Remission Clinical Trial (DiRECT) demonstrated that remission of type 2 diabetes can be achieved through substantial weight loss using a total diet replacement (TDR) intervention combined with structured support. Whether this approach can be delivered exclusively via eHealth has not been well studied.</p><p><strong>Objective: </strong>This pilot study aimed to evaluate whether a TDR intervention delivered solely via eHealth could induce clinically meaningful weight loss and achieve type 2 diabetes remission.</p><p><strong>Methods: </strong>This was a single-arm, nonblinded, single-center pilot study conducted at the clinical research facilities of Umeå University Hospital. Individuals with type 2 diabetes diagnosed within the past 6 years were included. Participants followed a TDR (~850 kcal/d) for 12 weeks, and then gradually reintroduced food, with a total study duration of 6 months. Diabetes medications were discontinued at the start of the study. Daily body weight and fasting glucose were measured at home and transmitted to the study team via connected devices. All clinical support was delivered through video calls and chat. The 2 prespecified coprimary outcomes were a reduction in weight of 15 kg or more and remission of diabetes, defined as glycated hemoglobin below 6.5% without glucose-lowering medication, from baseline to 6 months. A 75 g oral glucose tolerance test and indirect calorimetry were performed at baseline and at 6 months to assess resting energy expenditure (REE) and respiratory quotient (RQ).</p><p><strong>Results: </strong>Ten participants (mean age 58.5, SD 7.4 y; mean BMI 35.3, SD 5.9 kg/m²; n=9 men and n=1 woman) were enrolled. After 6 months, 6 of 10 participants achieved the prespecified coprimary outcome of ≥15 kg weight loss, and all 10 participants achieved the prespecified coprimary outcome of diabetes remission. Mean weight loss was 16.9 (SD 5.4; <i>P</i>=.005) kg, and glycated hemoglobin decreased by 1.0% (SD 0.8%<i>; P</i>=.008). Daily home measurements showed a marked reduction in fasting glucose within the first week of the intervention. Median REE decreased by 19% (IQR 17%-22%), while median fasting RQ increased by 15% (IQR 5%-27%) and median post-glucose-load RQ increased by 12% (IQR 9%-18%) at 6 months.</p><p><strong>Conclusions: </strong>In this pilot study, an eHealth-delivered TDR intervention was associated with substantial weight loss and diabetes remission at 6 months without the use of glucose-lowering medication. These findings support further evaluation of fully eHealth-delivered dietary interventions in larger and longer-term randomized controlled trials.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e93074"},"PeriodicalIF":2.9,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13641317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-09-30DOI: 10.2196/87688
Kara Mizokami-Stout, Kira Voelker, Melissa DeJonckheere, Lynn Ang, Evan L Reynolds, Joyce M Lee, Rodica Pop-Busui, Brian C Callaghan, Emily Hirschfeld, Jennifer J Iyengar, Dana Albright
{"title":"Real-Time Psychological Factors Using Ecological Momentary Assessment With Continuous Glucose Monitoring in Diabetes Mellitus: Scoping Review.","authors":"Kara Mizokami-Stout, Kira Voelker, Melissa DeJonckheere, Lynn Ang, Evan L Reynolds, Joyce M Lee, Rodica Pop-Busui, Brian C Callaghan, Emily Hirschfeld, Jennifer J Iyengar, Dana Albright","doi":"10.2196/87688","DOIUrl":"https://doi.org/10.2196/87688","url":null,"abstract":"<p><strong>Background: </strong>Ecological momentary assessment (EMA) is a tool that captures emotional states, experiences, and behaviors in real or near-real time. Concurrent EMA and continuous glucose monitoring (CGM) data can provide an in-depth understanding of the impacts of psychosocial factors on momentary glucose levels. However, study methodology varies widely for EMA and CGM data collection and analysis.</p><p><strong>Objective: </strong>This scoping review aims to summarize the objectives, methodologies, and outcomes of studies analyzing concurrent biopsychosocial EMA and CGM data in diabetes.</p><p><strong>Methods: </strong>This study was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Original research studies evaluating participants with diabetes, with concurrent collection and analysis of EMA and CGM data, were included in this review. A total of 782 studies were identified from PubMed, Embase, and EBSCOhost from May 2009 to December 2025. From these, duplicates, non-original research articles, and articles not measuring concurrent EMA and CGM data were excluded, resulting in a total of 19 studies included in this review. Methodological data were abstracted and summarized, including study characteristics, EMA protocols and outcomes, CGM outcomes, and integrated EMA and CGM study objectives. Methodological gaps across the included studies were identified and summarized.</p><p><strong>Results: </strong>Of the 19 studies, 16 primarily recruited adult populations, and the majority of these studies (n=14, 74%) included participants with type 1 diabetes. The median EMA delivery duration was 14 days (range 3-18 days), with a median of 5.5 prompts delivered per day (range 1-28). EMA outcomes included a variety of biopsychosocial factors (emotion, self-care behaviors, interpersonal interactions, symptoms, and cognition). Seventy-four percent analyzed blinded CGM data over a median of 14 (range 3-18) days. Forty-two percent used nonstandardized CGM glucose outcomes (postprandial glucose, eating patterns, and hypoglycemic events). Integrated EMA and CGM data analysis answered a broad array of study objectives, including the impact of psychosocial factors on momentary glucose metrics; the influence of momentary glucose on emotional states, mood, personal behaviors, sleep, and cognition, or vice versa; and study protocol or mobile app optimization, among others. Methodological gaps included lack of standardization of EMA and CGM outcomes, duration of data capture, reporting of statistical analyses, and study population.</p><p><strong>Conclusions: </strong>This review provides a detailed summary of the methodology and outcomes of original research articles using combined EMA and blood glucose data measured via CGM. These combined methods allow for an opportunity to elucidate relationships between psychosocial factors and momentary glucose, an under","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e87688"},"PeriodicalIF":2.9,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13626547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-09-25DOI: 10.2196/79648
Guillermo Molina-Recio, Ana-Belen Ariza-Jimenez, Alberto Membrillo-Del Pozo, Sandra Zafrilla-Sanchez, Jose Alvarez-Moral, Jose-Luis Velez-Leon, Rosa Gonzalez-Illanes, Rafael Molina-Luque
{"title":"SMARTCLOTH-Odyssey for Nutrition Education in Type 1 Diabetes: Development and Acceptability Study of a Gamified Web-Based Platform for Diabetes Nurse Educators Using a Human-Centered Design Approach.","authors":"Guillermo Molina-Recio, Ana-Belen Ariza-Jimenez, Alberto Membrillo-Del Pozo, Sandra Zafrilla-Sanchez, Jose Alvarez-Moral, Jose-Luis Velez-Leon, Rosa Gonzalez-Illanes, Rafael Molina-Luque","doi":"10.2196/79648","DOIUrl":"10.2196/79648","url":null,"abstract":"<p><strong>Background: </strong>The onset of type 1 diabetes mellitus (T1DM) in adolescence represents a challenge for patients, families, and health care professionals. Diabetes nurse educators identify a lack of adolescent-friendly educational resources, especially in nutrition education. Digital technology offers an opportunity to develop innovative tools to address these needs from a user-centered approach.</p><p><strong>Objective: </strong>We aimed to design and evaluate the acceptability of the SMARTCLOTH-Odyssey platform, an interactive web tool designed to support diabetes nurse educators in delivering nutrition education based on carbohydrate counting to adolescents with recent T1DM, evaluated from the perspective of nurse educators.</p><p><strong>Methods: </strong>A mixed study was carried out in three phases: (1) qualitative analysis through two focus groups with nurse educators in the Andalusian Community to identify barriers and needs; (2) development of the digital tool following a human-centered design methodology, incorporating narrative and gamified elements; and (3) quantitative evaluation of acceptability through an ad hoc questionnaire applied to 40 professionals who tested the platform.</p><p><strong>Results: </strong>Participants highlighted the lack of homogeneous and adapted debut materials, and the need for emotionally sensitive and visually appealing tools. SMARTCLOTH-Odyssey was rated positively in terms of usefulness, clarity, and clinical applicability. A total of 97.5% (39/40) felt it could facilitate nutrition education, and 90% (36/40) said they would use it in their practice. The platform was perceived as intuitive, innovative, and adapted to the characteristics of the adolescent patient.</p><p><strong>Conclusions: </strong>SMARTCLOTH-Odyssey constitutes a viable and well-valued proposal by nurse educators. It has the potential to improve nutrition education from the diagnosis of T1DM. Its participatory development reinforces its applicability and sustainability in real clinical contexts.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e79648"},"PeriodicalIF":2.9,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149065906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-09-04DOI: 10.2196/102715
Zhaohua Wang, Daniel Lane, Kayo Waki
{"title":"Toward Robust AI-Assisted Dietary Assessment for Diabetes Self-Management: Quantifying and Decomposing Large Language Model Prediction Variability From Meal Images.","authors":"Zhaohua Wang, Daniel Lane, Kayo Waki","doi":"10.2196/102715","DOIUrl":"10.2196/102715","url":null,"abstract":"<p><strong>Unlabelled: </strong>Nutrient estimation from meal images by multimodal large language models can support diabetes self-management, but its robustness is limited by variability driven by both sensitivity to visual presentation and inherent model instability. Accounting for and mitigating this variability is essential for robust AI-assisted dietary assessment.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e102715"},"PeriodicalIF":2.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13544413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-09-03DOI: 10.2196/106290
Nisha G Arya, Victoria Koltchine, Talia C Gearinger, Sherianne Buehler, Reza Yousefi-Nooraie, Rajeev S Ramchandran
{"title":"Implementing Diabetic Eye Care in Rural Primary Care Through Teleophthalmology and Pop-Up Clinics: Mixed Methods Study.","authors":"Nisha G Arya, Victoria Koltchine, Talia C Gearinger, Sherianne Buehler, Reza Yousefi-Nooraie, Rajeev S Ramchandran","doi":"10.2196/106290","DOIUrl":"10.2196/106290","url":null,"abstract":"<p><strong>Background: </strong>Diabetic retinopathy is the leading cause of blindness in US adults. Fewer than half of patients with diabetes in rural areas complete the recommended screening that could prevent blindness. Store-and-forward teleophthalmology and mobile pop-up eye clinics have each been shown to improve screening access, but studies examining the implementation of both modalities within the same rural primary care system are lacking.</p><p><strong>Objective: </strong>This study aimed to identify multilevel facilitators and barriers to implementing teleophthalmology and pop-up eye clinics for diabetic eye care in 2 rural primary care clinics in upstate New York.</p><p><strong>Methods: </strong>We conducted a mixed methods implementation study with prospective semistructured interviews and retrospective, descriptive electronic health record data at 2 university-affiliated primary care clinics classified as \"isolated rural,\" guided by the Consolidated Framework for Implementation Research (CFIR). Electronic health record data from 885 adults with diabetes were used to characterize patient demographics and eye care use. Patients were categorized into 3 groups: eye exam with an eye doctor (n=586), on-site primary care-based eye exam (n=91; teleophthalmology n=39 and pop-up clinic n=52), or no recent eye exam (n=208). Semistructured interviews were conducted with 20 patients (n=5 per subgroup) and 14 staff members (primary care clinicians, optometrists, and administrative personnel), purposively sampled to capture diverse perspectives across eye care pathways and roles. Interviews were coded using CFIR domains and analyzed thematically until no new themes emerged.</p><p><strong>Results: </strong>Patients in the on-site primary care eye exam group were the most socially disadvantaged, with the lowest proportions reporting no transportation needs (42/91, 46.2%), no housing instability (28/91, 30.8%), and no food insecurity (36/91, 39.6%). Over 18 months, 58.4% (52/89) of scheduled pop-up clinic appointments were completed, and 92.3% (36/39) of teleophthalmology images were gradable. Pop-up clinics detected higher rates of diabetic retinopathy (11/52, 21.2% vs 3/39, 7.7%), cataract (29/52, 55.8% vs 3/39, 7.7%), and reduced visual acuity (23/52, 44.2% vs 11/39, 28.2%) than teleophthalmology. Qualitative analysis revealed that patients viewed both modalities as a convenient \"one-stop shop\" and valued trust in primary care staff. Staff identified complementary barriers: training and workflow complexity for teleophthalmology, and underutilization and scheduling challenges for pop-up clinics. Implementation champions across roles proposed an integrated workflow in which same-day teleophthalmology becomes a default component of annual diabetes visits, with targeted referral to pop-up clinics for patients with abnormal findings.</p><p><strong>Conclusions: </strong>Primary care-based eye programs in rural settings preferentially reached socially v","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e106290"},"PeriodicalIF":2.9,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13541231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148889222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JMIR DiabetesPub Date : 2026-08-26DOI: 10.2196/87590
Chloe Stallion, Tamkeen Khan, Christian Guerrero, Stavros Tsipas, Gregory Wozniak
{"title":"Social Media Discussions of Anti-Diabetic Drugs and the Popularity of GLP-1 Therapies: Content Analysis.","authors":"Chloe Stallion, Tamkeen Khan, Christian Guerrero, Stavros Tsipas, Gregory Wozniak","doi":"10.2196/87590","DOIUrl":"10.2196/87590","url":null,"abstract":"<p><strong>Background: </strong>The clinical use of antidiabetic drugs (ADDs) has gained prominent public visibility due to the Food and Drug Administration (FDA) expansion of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in recent years; these drugs are now widely prescribed for weight loss. This shift is reflected in online public discourse.</p><p><strong>Objective: </strong>This study aimed to analyze the current online public discourse surrounding ADDs, with an emphasis on perceptions of insulin versus noninsulin therapies and the increasing prominence of weight loss-associated medications.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of 23,580 English-language posts from the United States in 2023, using Boolean keyword searches to examine conversations about insulin-inclusive, with or without weight loss terms, and insulin-exclusive, with or without weight loss terms. We analyzed the volume and sentiment of online conversations regarding ADDs, frequency of drug mentions, proportion of posts by self-identified physicians, and thematic analysis of patient and clinician concerns.</p><p><strong>Results: </strong>A total of 26,832 initial posts were collected in 2023. After post validation, 23,580 posts remained as the study sample size. Of the 23,580 posts, 4.6% (1087/23,580) mentioned insulin, and 95.4% (n=22,493) did not mention insulin. Semaglutide-containing drugs such as Ozempic and Mounjaro were the most referenced medications, particularly in weight-loss contexts. Weight loss conversations made up the majority of online posts. Conversations about insulin were marginal compared with conversations that did not mention insulin online. Only 7% to 10% of posts came from self-identified physicians. Key themes included drug accessibility, off-label use for weight management, concerns about supply shortages, insurance coverage, and growing calls for holistic care. Notably, public perspectives favored the dual efficacy of medications like Ozempic in managing diabetes and promoting weight loss.</p><p><strong>Conclusions: </strong>The discourse on ADDs is dominated by weight loss-oriented therapies, with GLP-1 RAs driving much of the engagement. This surveillance paper illustrates the current state of public health interests around antidiabetic medications associated with weight loss and raises concerns regarding equitable access for patients with diabetes. These findings underscore the need for updated clinical guidance on necessary lifestyle behaviors for antidiabetic medication use and ongoing monitoring of public opinions regarding chronic disease management medications.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"11 ","pages":"e87590"},"PeriodicalIF":2.9,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13515349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148882695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}